To clarify this issue, we established HMGB1-knockout clones from B16F10 and CT26 tumor cells by genome editing using the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system, and used these clones to investigate the role of HMGB1 on the anti-tumor immunity. The gene discussed is HMGB1; the disease is neoplasm.